» Articles » PMID: 10788227

FDA Regulation of Medical Software

Overview
Journal J Health Law
Date 2000 May 2
PMID 10788227
Authors
Affiliations
Soon will be listed here.
Abstract

Currently the FDA is reviewing its policy on the regulation of computer software in the medical arena. Healthcare practitioners hope that the FDA will take the least possible regulatory action required by law to fulfill its public health responsibility and will take into account the unique status of the ever-changing software industry. Innovations in telemedicine and medical informatics have yielded significant improvements in the quality and cost of healthcare, and the imposition of cumbersome regulatory requirements on the medical software industry would slow the development and introduction of medical software products.